Author

Angie R. Emanuel

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5008551350

Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

2019 · Prashant Kapoor, Morie A. Gertz, et al. · Blood · 13

Works count: 1

Citation count: 13

H-index: 1

I10-index: 1